855. Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals

BACKGROUND: Many antimicrobial stewardship programs have set goals to reduce the use of fluoroquinolones because of risks of causing C. difficile and other adverse safety events. The US Food and Drug Administration issued a black box label warning for fluoroquinolones in June 2016 recommending avoid...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Yarrington, Michael, Anderson, Deverick J, Ashley, Elizabeth Dodds, Jones, Travis, Johnson, Melissa, Lokhnygina, Yuliya, Sexton, Daniel, Moehring, Rebekah W
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6252437/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy209.040
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky